What is Nvidia’s New $1 Trillion SuperProject?

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

LCTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 28.10%

Insider Buying (Last 12 Months): $7,119,847.00

Insider Selling (Last 12 Months): $0.00

Lineage Cell Therapeutics Insider Trading History Chart

Lineage Cell Therapeutics Share Price & Price History

^$0.84

▼ -0.04 (-4.57%)

As of 09/6/2024 01:00 AM ET

Days: 30 | 90 | 365

Say Goodbye to the US Dollar

From Sasco Gold LLC | Ad

The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." I believe the American people deserve to control the fate of their own life savings which is why I had my team put together our latest guide to protect your hard-earned wealth before it's too late...

[RUSH MY FREE GUIDE]

Lineage Cell Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/16/2024	Jill Ann Howe	CFO	Buy	10,500	$0.89	$9,345.00	10,500
5/24/2024	Brian M Culley	CEO	Buy	10,000	$1.05	$10,500.00	154,842
2/8/2024	Don M Bailey	Director	Buy	96,155	$1.04	$100,001.20	158,801
2/6/2024	Broadwood Partners, L.P.	Director	Buy	6,730,770	$1.04	$7,000,000.80	41,666,255
3/31/2022	Brian M Culley	CEO	Buy	6,400	$1.53	$9,792.00	97,787
3/28/2022	Dipti Amin	Director	Buy	35,000	$1.63	$57,050.00
3/25/2022	Brian M Culley	CEO	Buy	5,250	$1.38	$7,245.00
3/24/2022	Michael H Mulroy	Director	Buy	7,000	$1.40	$9,800.00
12/28/2021	Gary S Hogge	SVP	Sell	501,588	$2.45	$1,228,890.60

The death of Nvidia?

From Porter & Company | Ad

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

SEC Filings (Institutional Ownership Changes) for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)

62.47% of Lineage Cell Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Lineage Cell Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/27/2024	Logos Global Management LP	4,700,000	$4.69M	0.4%	-24.8%	2.489%
8/14/2024	Raffles Associates LP	4,357,781	$4.35M	4.9%	+35.8%	2.308%
8/14/2024	Logos Global Management LP	4,700,000	$4.69M	0.4%	-24.8%	2.489%
8/12/2024	XTX Topco Ltd	61,515	$61K	0.0%	N/A	0.033%
8/9/2024	Renaissance Technologies LLC	583,622	$0.58M	0.0%	+10.0%	0.309%
8/1/2024	Rhumbline Advisers	132,491	$0.13M	0.0%	+15.1%	0.070%
7/26/2024	Bank of New York Mellon Corp	435,958	$0.44M	0.0%	+35.7%	0.231%
5/17/2024	Comerica Bank	250,295	$0.37M	0.0%	+84,745.8%	0.133%
5/15/2024	Price T Rowe Associates Inc. MD	161,314	$0.24M	0.0%	+77.5%	0.085%
5/10/2024	Vanguard Group Inc.	8,373,771	$12.39M	0.0%	-0.1%	4.435%
4/16/2024	Fifth Third Wealth Advisors LLC	20,000	$30K	0.0%	N/A	0.011%
2/13/2024	DCF Advisers LLC	94,751	$0.10M	0.1%	+14.5%	0.054%
1/23/2024	Defender Capital LLC.	4,969,675	$5.42M	1.9%	-4.1%	2.840%
1/12/2024	SG Americas Securities LLC	30,889	$34K	0.0%	+61.6%	0.018%
12/6/2023	Citigroup Inc.	133,051	$0.16M	0.0%	-16.2%	0.076%
11/15/2023	Laurion Capital Management LP	1,136,471	$1.34M	0.0%	-42.2%	0.649%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	182,561	$0.22M	0.0%	-27.9%	0.104%
11/13/2023	Rathbones Group PLC	35,000	$41K	0.0%	N/A	0.020%
10/23/2023	Defender Capital LLC.	5,184,510	$6.12M	2.2%	+1.5%	2.963%
9/21/2023	Barclays PLC	25,905	$36K	0.0%	+87.3%	0.015%
8/15/2023	Raffles Associates LP	1,597,739	$2.25M	3.0%	+4.0%	0.913%
8/4/2023	American International Group Inc.	62,114	$88K	0.0%	N/A	0.036%
8/2/2023	MAI Capital Management	951,578	$1.34M	0.0%	+123.8%	0.545%
8/1/2023	Fort Sheridan Advisors LLC	83,931	$0.12M	0.0%	+13.5%	0.049%
7/18/2023	Defender Capital LLC.	5,109,710	$7.20M	2.5%	-0.5%	3.003%
7/10/2023	Trust Co. of Toledo NA OH	35,394	$50K	0.0%	+41.6%	0.021%
6/1/2023	Prelude Capital Management LLC	16,688	$25K	0.0%	N/A	0.010%
5/15/2023	Fort Sheridan Advisors LLC	73,931	$0.11M	0.0%	-11.9%	0.043%
5/12/2023	Long Focus Capital Management LLC	175,000	$0.26M	0.0%	-18.6%	0.103%
5/11/2023	PFG Investments LLC	20,200	$30K	0.0%	N/A	0.012%
5/10/2023	Summit X LLC	21,925	$33K	0.0%	-26.7%	0.013%
5/10/2023	MAI Capital Management	425,115	$0.64M	0.0%	-6.9%	0.250%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	241,022	$0.36M	0.0%	-8.0%	0.142%
5/9/2023	Y Intercept Hong Kong Ltd	66,298	$99K	0.0%	N/A	0.039%
5/5/2023	Truist Financial Corp	42,591	$64K	0.0%	N/A	0.025%
5/1/2023	Virtu Financial LLC	17,521	$26K	0.0%	-60.6%	0.010%
4/27/2023	Defender Capital LLC.	5,136,085	$7.70M	2.7%	+0.8%	3.019%
4/27/2023	Simplicity Solutions LLC	48,000	$72K	0.0%	N/A	0.028%
4/20/2023	Strategic Wealth Investment Group LLC	18,553	$47K	0.0%	-41.2%	0.011%
4/18/2023	ETF Managers Group LLC	318,596	$0.48M	0.0%	-10.0%	0.187%
4/4/2023	Trust Co. of Toledo NA OH	25,000	$38K	0.0%	N/A	0.015%
3/23/2023	ETF Managers Group LLC	353,991	$0.41M	0.0%	+7.3%	0.208%
2/14/2023	683 Capital Management LLC	128,840	$0.15M	0.0%	N/A	0.076%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	261,902	$0.31M	0.0%	-9.2%	0.154%
2/9/2023	MAI Capital Management	456,817	$0.53M	0.0%	-12.5%	0.269%
2/9/2023	Citigroup Inc.	477,174	$0.56M	0.0%	+250.9%	0.281%
2/8/2023	Lincoln National Corp	155,700	$0.18M	0.0%	-28.5%	0.092%
1/12/2023	Defender Capital LLC.	5,093,535	$5.96M	2.4%	-1.7%	2.997%
11/15/2022	Laurion Capital Management LP	2,377,940	$2.69M	0.0%	-1.8%	1.399%
11/15/2022	ETF Managers Group LLC	329,826	$0.37M	0.0%	+8.2%	0.194%
11/14/2022	Raffles Associates LP	2,080,536	$2.35M	2.5%	+7.8%	1.226%
11/14/2022	Lazard Asset Management LLC	77,974	$88K	0.0%	N/A	0.046%
11/14/2022	Ergoteles LLC	490,895	$0.56M	0.0%	-11.3%	0.289%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	288,299	$0.33M	0.0%	+113.0%	0.170%
11/10/2022	Phoenix Holdings Ltd.	47,587	$55K	0.0%	-73.2%	0.028%
11/4/2022	Lincoln National Corp	217,700	$0.25M	0.0%	-13.4%	0.128%
10/21/2022	Strategic Wealth Investment Group LLC	37,008	$42K	0.0%	-25.6%	0.022%
10/18/2022	Defender Capital LLC.	5,184,035	$5.86M	2.3%	+1.0%	3.054%
8/15/2022	Laurion Capital Management LP	2,422,367	$3.83M	0.1%	N/A	1.427%
8/10/2022	Dowling & Yahnke LLC	32,263	$51K	0.0%	N/A	0.019%
8/8/2022	Y Intercept Hong Kong Ltd	44,829	$71K	0.0%	N/A	0.026%
8/8/2022	Strategic Wealth Investment Group LLC	49,736	$79K	0.0%	-20.4%	0.029%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	135,328	$0.21M	0.0%	+1,027.7%	0.080%
8/2/2022	Lincoln National Corp	251,500	$0.40M	0.0%	+30.4%	0.148%
7/26/2022	Defender Capital LLC.	5,131,935	$8.11M	3.2%	+2.5%	3.024%
7/19/2022	MAI Capital Management	247,735	$0.39M	0.0%	N/A	0.146%
6/7/2022	Defender Capital LLC.	5,006,185	$7.98M	2.8%	+0.2%	2.949%
5/11/2022	GSA Capital Partners LLP	72,506	$0.11M	0.0%	N/A	0.043%
5/10/2022	Phoenix Holdings Ltd.	111,545	$0.17M	0.0%	-9.9%	0.066%
5/9/2022	Fort Sheridan Advisors LLC	75,931	$0.12M	0.0%	+43.5%	0.045%
4/28/2022	DekaBank Deutsche Girozentrale	402,100	$0.61M	0.0%	+10.0%	0.237%
2/15/2022	Raffles Associates LP	543,590	$1.33M	1.3%	+480.8%	0.322%
2/14/2022	Long Focus Capital Management LLC	215,000	$0.53M	0.1%	N/A	0.128%
2/14/2022	DAFNA Capital Management LLC	80,000	$0.20M	0.0%	N/A	0.047%
2/14/2022	ETF Managers Group LLC	207,735	$0.52M	0.0%	N/A	0.123%
2/14/2022	Williams Jones Wealth Management LLC.	101,300	$0.25M	0.0%	N/A	0.060%
2/10/2022	Bailard Inc.	63,400	$0.16M	0.0%	N/A	0.038%
2/9/2022	Principal Financial Group Inc.	78,742	$0.19M	0.0%	-36.6%	0.047%
2/9/2022	Lazard Asset Management LLC	21,610	$52K	0.0%	N/A	0.013%
2/8/2022	ProShare Advisors LLC	27,397	$67K	0.0%	+70.5%	0.016%
2/8/2022	Northern Trust Corp	1,080,924	$2.65M	0.0%	-27.8%	0.641%
2/7/2022	SG Americas Securities LLC	31,542	$77K	0.0%	-58.4%	0.019%
2/7/2022	Phoenix Holdings Ltd.	123,866	$0.31M	0.0%	N/A	0.073%
2/2/2022	DekaBank Deutsche Girozentrale	365,500	$0.89M	0.0%	-33.5%	0.217%
2/1/2022	Defender Capital LLC.	4,997,870	$12.25M	3.9%	+4.2%	2.965%
1/28/2022	Allspring Global Investments Holdings LLC	522,913	$1.28M	0.0%	N/A	0.310%
1/26/2022	Straight Path Wealth Management	16,200	$40K	0.0%	N/A	0.010%
1/26/2022	Lincoln National Corp	193,500	$0.47M	0.0%	+25.2%	0.115%
1/12/2022	Value Partners Investments Inc.	150,000	$0.37M	0.0%	+25.0%	0.089%
1/10/2022	Patriot Financial Group Insurance Agency LLC	24,000	$59K	0.0%	-36.8%	0.014%
12/8/2021	Moors & Cabot Inc.	18,400	$47K	0.0%	-21.2%	0.011%
11/16/2021	Two Sigma Advisers LP	1,112,366	$2.80M	0.0%	-39.0%	0.664%
11/16/2021	Two Sigma Investments LP	580,788	$1.46M	0.0%	-55.8%	0.347%
11/16/2021	Two Sigma Securities LLC	96,762	$0.24M	0.0%	N/A	0.058%
11/16/2021	Metropolitan Life Insurance Co NY	19,078	$48K	0.0%	-50.7%	0.011%
11/15/2021	HighTower Advisors LLC	33,316	$84K	0.0%	+104.2%	0.020%
11/12/2021	Laidlaw Wealth Management LLC	104,841	$0.26M	0.1%	-15.3%	0.063%
11/12/2021	E Fund Management Co. Ltd.	11,095	$28K	0.0%	N/A	0.007%
11/10/2021	Goldman Sachs Group Inc.	97,071	$0.25M	0.0%	+625.8%	0.058%
11/10/2021	Citigroup Inc.	137,858	$0.35M	0.0%	+1,082.0%	0.082%

Data available starting January 2016

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for unmet medical needs in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the treatment of cervical spinal cord injuries; and VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers ANP1, an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of debilitating hearing loss; and PNC1, an allogeneic photoreceptor cell transplant, which is in preclinical development for the treatment of vision loss due to photoreceptor dysfunction or damage. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Immunomic Therapeutics, Inc., for the treatment of glioblastoma multiforme. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.

Today's Range

Now: $0.84

$0.83

$0.89

50 Day Range

MA: N/A

52 Week Range

Now: $0.84

$0.77

$1.61

Volume

376,589 shs

Average Volume

873,955 shs

Market Capitalization

$157.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of Lineage Cell Therapeutics?: Lineage Cell Therapeutics' top insider investors include:
Broadwood Partners, LP (Director)
Don M Bailey (Director)
Brian M Culley (CEO)
Jill Ann Howe (CFO)
Learn More about top insider investors at Lineage Cell Therapeutics.
Who are the major institutional investors of Lineage Cell Therapeutics?: Lineage Cell Therapeutics' top institutional shareholders include:
Logos Global Management LP — 2.49%
Logos Global Management LP — 2.49%
Raffles Associates LP — 2.31%
Renaissance Technologies LLC — 0.31%
Bank of New York Mellon Corp — 0.23%
Rhumbline Advisers — 0.07%
Learn More about top institutional investors of Lineage Cell Therapeutics stock.
Which major investors are selling Lineage Cell Therapeutics stock?: Within the previous quarter, LCTX stock was sold by these institutional investors:
Logos Global Management LP
Logos Global Management LP
Which major investors are buying Lineage Cell Therapeutics stock?: During the previous quarter, LCTX stock was acquired by institutional investors including:
Raffles Associates LP
Bank of New York Mellon Corp
XTX Topco Ltd
Renaissance Technologies LLC
Rhumbline Advisers
Within the previous year, these company insiders have bought Lineage Cell Therapeutics stock:
Broadwood Partners, LP (Director)
Don M Bailey (Director)
Brian M Culley (CEO)
Jill Ann Howe (CFO)
Learn More investors buying Lineage Cell Therapeutics stock.